SMTL ID : 9eus.1

Mpro from SARS-CoV-2 with R298A mutation

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 5 residues within 4Å: Chain A: D.33, T.98, P.99, K.100, Y.101 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.101, A:Y.101 GOL.2: 7 residues within 4Å: Chain A: R.4, K.5 Chain B: K.5, Y.126, Q.127, E.290 Ligands: GOL.3 4 PLIP interactions: 3 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:R.4, A:K.5, A:K.5, B:Q.127 GOL.3: 6 residues within 4Å: Chain A: K.5, Y.126, Q.127 Chain B: R.4, K.5 Ligands: GOL.2 5 PLIP interactions: 3 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:K.5, A:Q.127, A:Q.127, B:R.4, B:K.5

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lis, K. et al., SARS-CoV-2 M pro oligomerization as a potential target for therapy. Int.J.Biol.Macromol. (2024)

Release Date

2024-04-17

Peptides

Replicase polyprotein 1a: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Replicase polyprotein 1a